UNI-EN 38:Current report 38 Momina krepost AD above 50%
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 38 | / | 2013 | | ||||||
| Date of issue: | 2013-03-21 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 38 Momina krepost AD above 50% | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD announces that the Company bought 770 ordinary registered shares with voting rights, representing 0.0455 of the share of the capital of Momina krepost AD. After this transaction the share of Sopharma AD in the capital of Momina krepost AD increased above 50% to 50.015%. Sopharma will undertake the actions envisaged by the Law for public offering of securities art. 149 in relation to the fact that it now has exceeded the threshold of 50% in the capital of Momina krepost AD. The highest price on which the company has purchased shares of Momina krepost AD in the last six months is 3 BGN. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 38 Momina krepost AD above 50%.doc Current report 38 Momina krepost AD above 50%.doc | Current report 38 Momina krepost AD above 50% | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-03-21 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
